Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
207M
-
Number of holders
-
123
-
Total 13F shares, excl. options
-
16.6M
-
Shares change
-
-366K
-
Total reported value, excl. options
-
$392M
-
Value change
-
-$218M
-
Put/Call ratio
-
1.01
-
Number of buys
-
73
-
Number of sells
-
-83
-
Price
-
$23.59
Significant Holders of Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) as of Q3 2015
195 filings reported holding ESPR - Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q3 2015.
Esperion Therapeutics, Inc. - Common Stock, par value $0.001 per share (ESPR) has 123 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16.6M shares
of 207M outstanding shares and own 8.01% of the company stock.
Largest 10 shareholders include FMR LLC (2.54M shares), Aisling Capital LLC (1.64M shares), Pentwater Capital Management LP (1.45M shares), BB BIOTECH AG (909K shares), COLUMBUS CIRCLE INVESTORS (739K shares), STATE STREET CORP (728K shares), VANGUARD GROUP INC (727K shares), WASATCH ADVISORS INC (690K shares), DISCOVERY CAPITAL MANAGEMENT, LLC / CT (524K shares), and DEUTSCHE BANK AG\ (488K shares).
This table shows the top 123 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.